John Ripple serves as owner and Principal Consultant of Ripple Biotech, LCC, advising organizations on strategy, business development, and capital fundraising activities. He previously served as CEO of several venture-backed biotech companies including Exonics Therapeutics (acquired by Vertex); Virdante Pharmaceuticals (acquired by Momenta); and Syntonix Pharmaceuticals (acquired by Biogen).

Mr. Ripple also held positions in business development, medical device marketing, management consulting, and served as an entrepreneur-in-residence. Mr. Ripple received a BS in Mechanical Engineering from Bucknell University and an MBA from Harvard Business School.